4/9/2015Uni-Bio Science's Osteoporos NDA Accepted by CFDA

4/9/2015Tonghua Dongbao Pharma to Build $60M API Plant

4/9/2015More Chinese Pharma Cos Cuts Sales Force and Switch to Agency Sales

4/9/2015MIIT Publishes 2014 Chinese Pharmaceutical Company Ranking

4/8/2015Australian and Chinese Researchers Make Drug Research Breakthrough for...

4/8/2015Recent Executive Movements

4/8/2015GSK to Take Over China Vaccine Business from Novartis Following Global...

4/8/2015Hospital Oncology Drug Consumption of Six Cities in Yangtze River Vici...

4/8/2015Review of Drug Consumption in Chinese County Level Hospitals

4/8/2015Financial-related Company News in Brief

4/8/2015Resverlogix Receives Two Chinese Patents for Its BET Inhibitor

4/7/2015Global Strategic Partners Merck and Pfizer Finalize Agreement to Co-Pr...

4/7/2015Upcoming Event: Asia Healthcare Summit

4/7/2015Upcoming Event: ISPE

4/7/2015Upcoming Event: Biopharma Development & Production

4/6/2015Medidata Expands Partnership with PKU for Clinical Cloud-Based Technol...

4/6/2015MOHRSS Issues Adjustment Notice of the 2009 NDRL

4/3/2015Wuxi PharmaTech's CMO Subsidiary STA Approved for IPO in China

4/3/2015J&J CEO Pledges Long Term Commitment to China

4/3/2015Merck Expects Continued Double-digit Growth in China

4/3/2015Uremia Patients in Chongqing Protest Against Latest Healthcare Reform ...

4/3/2015Overweight and Obesity A Fast Rising Problem Among Younger Chinese Are

4/3/2015Covance and Sihuan Announce Partnership for Global Pipeline Developmen...

4/3/2015Pfizer to Suspend China Vaccine Business After CFDA's Import Renewal R...

4/3/2015Birth of A New Novel Anticancer, Made in China

4/1/2015New Report: Chinese Human Vaccine Output Down 2.4% in 2014

4/1/2015Upcoming Event: 7th DIA China Annual Meeting

4/1/2015CFDA Vice Minister YIN Li Transferred to Sichuan

4/1/2015CDE Solicits Feedbacks on Bioavailability and Bioequivalence Guideline

4/1/2015Local Governments Catches the NHFPC Momentum to Contain Drug Costs

Page:442/775 Total number of articles:23233: [First][<<] [440] [441] [442] [443] [444] [>>] [End]